ADH5 and neoplasm: Metabolic genes CYP1B1, AANAT, ADH5, and ALDH3A2, associated with the serotonin and melatonin biosynthesis pathway, contribute to tumour growth, immune modulation, and altered metabolic states in the TME (Figure S6).